Phenol-Explorer 2.0: a major update of the Phenol-Explorer database integrating data on polyphenol metabolism and pharmacokinetics in humans and experimental animals by Rothwell, Joseph A. et al.
Database update
Phenol-Explorer 2.0: a major update of the
Phenol-Explorer database integrating data on
polyphenol metabolism and pharmacokinetics
in humans and experimental animals
Joseph A. Rothwell1, Mireia Urpi-Sarda2,3, Maria Boto-Ordon˜ez2,3,4, Craig Knox5,
Rafael Llorach4,6, Roman Eisner5, Joseph Cruz5, Vanessa Neveu7, David Wishart7,
Claudine Manach1, Cristina Andres-Lacueva4,6 and Augustin Scalbert1,8,*
1INRA, UMR1019, Unite´ Nutrition Humaine, CRNH Auvergne, Clermont-Ferrand F-63000, France, 2Department of Internal Medicine, Hospital Clinic,
Institut d’Investigacio´ Biome`dica August Pi i Sunyer (IDIBAPS), University of Barcelona, Villarroel 170, Barcelona 08036, Spain, 3CIBER 08/08:
Fisiopatologı´a de la Obesidad y la Nutricio´n and RD06/0045/1003 Alimentacio´n Saludable, Instituto de Salud Carlos III, Spain, 4Nutrition and Food
Science Department, Pharmacy Faculty, University of Barcelona, Av. Joan XXIII s/n, Barcelona 08028, Spain, 5In Siliflo Inc, Edmonton AB T5M 1K2,
Canada, 6Ingenio-CONSOLIDER program, FUN-C-FOOD, CSD5009-088, Barcelona, Spain, 7Department of Computing Science, University of Alberta,
Edmonton AB T6G 2E8, Canada and 8International Agency for Research on Cancer (IARC), Nutrition and Metabolism Section, Biomarkers Group,
150 cours Albert Thomas, F-69372 Lyon Cedex 08, France
*Corresponding author: Tel: +33 (0) 4 72 73 80 95; Email: scalberta@iarc.fr
Present address: Augustin Scalbert, International Agency for Research on Cancer (IARC), Lyon, France.
Submitted 21 March 2012; Revised 10 July 2012; Accepted 14 July 2012
.............................................................................................................................................................................................................................................................................................
Phenol-Explorer, launched in 2009, is the only comprehensive web-based database on the content in foods of polyphenols,
a major class of food bioactives that receive considerable attention due to their role in the prevention of diseases.
Polyphenols are rarely absorbed and excreted in their ingested forms, but extensively metabolized in the body, and
until now, no database has allowed the recall of identities and concentrations of polyphenol metabolites in biofluids
after the consumption of polyphenol-rich sources. Knowledge of these metabolites is essential in the planning of experi-
ments whose aim is to elucidate the effects of polyphenols on health. Release 2.0 is the first major update of the database,
allowing the rapid retrieval of data on the biotransformations and pharmacokinetics of dietary polyphenols. Data on 375
polyphenol metabolites identified in urine and plasma were collected from 236 peer-reviewed publications on polyphenol
metabolism in humans and experimental animals and added to the database by means of an extended relational design.
Pharmacokinetic parameters have been collected and can be retrieved in both tabular and graphical form. The web
interface has been enhanced and now allows the filtering of information according to various criteria. Phenol-Explorer
2.0, which will be periodically updated, should prove to be an even more useful and capable resource for polyphenol
scientists because bioactivities and health effects of polyphenols are dependent on the nature and concentrations of
metabolites reaching the target tissues. The Phenol-Explorer database is publicly available and can be found online at
http://www.phenol-explorer.eu.
Database URL: http://www.phenol-explorer.eu
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Introduction
Polyphenols are secondary plant metabolites abundant in
many plant foods (1). An average dietary intake of 1–2 g/
day has been reported in several Western populations with
fruits and beverages such as tea, coffee, wine and fruit
juices recognized as the major dietary sources (2, 3).
Polyphenols have long been known to exert a range of
biological activities, and their intake has been associated
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with a reduced risk of chronic diseases, such as coronary
heart disease, stroke, type 2 diabetes and some cancers in
various epidemiological studies and clinical trials (4–6). For
this reason, they are now regarded as important compo-
nents of a healthy diet and are thought to be partly respon-
sible for the health benefits of an increased fruit and
vegetable consumption (7). They may also explain the pro-
tective effects of tea against cardiovascular diseases (8, 9) or
of coffee against type 2 diabetes (10). In the last 15 years,
scientific and commercial interest in polyphenols has grown
dramatically, and several thousand studies investigating
their bioactivities, metabolism and health effects are pub-
lished every year.
Since its launch in 2009, the first release of Phenol-
Explorer (Phenol-Explorer 1.0) has aided such research
with its ability to generate an instant estimate of the poly-
phenol composition of a queried food, based on data from
as many quality-assessed publications as possible (11).
Similarly, it was possible to search for a phenolic food com-
ponent and retrieve all foods in which this polyphenol had
been identified, along with average concentrations. This
ease of data retrieval and comprehensive aggregation of
studies have made the database a unique and essential tool
for polyphenol scientists.
A detailed knowledge of the bioavailability of the vari-
ous polyphenols and the nature and concentrations of the
metabolites formed in the body is also essential to under-
stand their effects on health. Most polyphenols are glyco-
sylated in foods and are deglycosylated in the brush border
of the small intestine or by colonic microbiota and
re-conjugated to water-soluble glucuronides and sulfate
esters and methylated in the intestine and the liver (12).
Conjugated metabolites are then rapidly eliminated in
the bile and urine. Polyphenols not absorbed in the small
intestine are metabolized by the microbiota in the colon to
a variety of low-molecular-weight phenolic acids, which
may be absorbed into systemic circulation.
Knowledge of polyphenol metabolism has grown consid-
erably during the past decade, but data are inherently dif-
ficult to search for and place into context because of the
variable nature of doses, study organisms and time scales
used in experimental studies. This information is still scat-
tered in a large number of scientific publications, and its
analysis often requires laborious searches, and no dedi-
cated database has been available so far. More general
databases contain scattered information on polyphenol
metabolism; for example, the Human Metabolome
Database (http://www.hmdb.ca) contains data on some
polyphenols and gives example concentrations of the
parent compound in biofluids as observed after the con-
sumption of a few selected foods (13). Also, the Kyoto
Encyclopedia of Genes and Genomes (http://www
.genome.jp/kegg/) contains information on some polyphe-
nol metabolites (14). However, a large number of known
polyphenol metabolites are missing from these databases,
and the identities of phase II conjugates of a given poly-
phenol are not listed. Detailed pharmacokinetic data on
these compounds are not available.
Here, we report the second major release of Phenol-
Explorer (Phenol-Explorer 2.0), which extends the utility
of the database by allowing the retrieval of information
pertaining to the in vivo metabolism and pharmacokinetics
of dietary polyphenols. The database now includes identi-
ties of all known plasma and urinary polyphenol metabol-
ites together with detailed pharmacokinetic data. All food
sources that have been reported to give rise to one of these
metabolites can be retrieved. Finally, the results of these
searches are accompanied by detailed pharmacokinetic
data [maximum plasma concentration (Cmax), time to
reach Cmax (Tmax), area under concentration-time curve
(AUC), half-life of elimination (T1/2), urinary recovery and
plasma or urinary time courses where available. Searches
are made through the existing user-friendly and intuitive
web interface, and metabolism data are linked to food
composition data. We believe that this new release will
be the most powerful and useful resource to easily identify
those polyphenol metabolites and respective concentra-
tions most relevant for future experimental research or
most useful as biomarkers of exposure for future epidemio-
logical studies.
A limit of our current knowledge is that much of the
evidence on the role of polyphenols in the prevention of
chronic diseases arises from clinical trials where complex
polyphenol-rich foods were administered (6). More data
on the properties and effects of individual polyphenols
are clearly needed, and this implies the collection and use
of detailed information on food composition and polyphe-
nol metabolism, as well as new clinical trials with pure poly-
phenol supplements (15).
Compilation of data and
implementation of the update
A systematic search was performed for literature on poly-
phenol metabolism, published up until 1 March 2011.
Search terms were built from a template that included
the biofluid analyzed, the selected animal or human species
and the names of the polyphenols and polyphenol classes
of interest (Table 1), and these were applied in parallel to
three databases: the Cochrane Library (from 1800; www
.thecochranelibrary.com), MEDLINE Pubmed (from 1950,
www.pubmed.org) and the ISI Web of Knowledge Science
Citation Index Expanded (1945 to present). The publications
retrieved were compiled and organized using Endnote
(Thomson Reuters, New York, NY).
After the screening of titles and abstracts, reviews,
in vitro studies and any duplicates were excluded
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(Figure 1). Of the remainder, full-text articles were ob-
tained for more detailed analyses. Articles were subse-
quently included or excluded according to various criteria.
For inclusion, studies needed to (i) be conducted in vivo on
humans or animals; (ii) be intervention studies using a
single or repeated dose of a normal food source, an experi-
mental food or an oral supplement; (iii) use an appropriate
analytical technique, preferably mass spectrometry, cap-
able of reliably identifying metabolites; (iv) detect or quan-
tify at least one polyphenol metabolite in urine or plasma;
(v) use disease-free humans or animals as subjects; (vi) pre-
sent data in a usable format and (vii) be published in
English. In addition, some articles were rejected at the com-
pilers’ discretion due to a lack of clarity or essential infor-
mation or due to an excessively complex study design.
Finally, only metabolites with fully defined structures
were included; for example, data on quercetin
3-glucuronide would be included but not, for example,
quercetin glucuronide, as quercetin may be glucuronidated
at different positions on the phenolic rings.
As with Phenol-Explorer 1.0, data were compiled by
means of a Microsoft Access database. The physical design
of Phenol-Explorer 1.0 consisted of five main tables (4).
Four of these were independent tables named Foods,
Publications, Compounds and Methods, whose records
were allocated autonumbers. A fifth table, Food
Composition, listed each concentration value collected as
a record, accompanied by codes linking to the food, publi-
cation, polyphenol quantified and method of analysis. To
incorporate metabolism data, two extra tables were added
(Figure 2). The Interventions table lists every separate inter-
vention experiment, defined as a combination of the dose
type, dose quantity and organism. Interventions table is
linked, by many-to-one relationships, to Foods and
Publications. The Biofluid Composition table lists
concentration values of metabolites in plasma or urine
and detailed temporal data. Biofluid Composition is
linked by many-to-one relationships with Interventions,
Compounds and Methods. The following is a description
of each of the seven tables and their contents.
Foods
In the Phenol-Explorer 1.0 release, the table only contained
foods representative of those regularly consumed in vari-
ous populations. For Phenol-Explorer 2.0, experimental
foods specific to a particular intervention study, such as
polyphenol-rich extracts, enzymatically modified foods or
pure polyphenol preparations, have been added.
Compounds
Fully defined polyphenol metabolites described in the
intervention studies were added to this table. Compound
classification was left unchanged from Phenol-Explorer 1.0,
although an extra class to include non-phenolic breakdown
products was added.
Publications
Bibliographic details for intervention studies were added to
this table.
Methods
Methods of analysis for metabolites in intervention studies
were classed as high performance liquid chromatography,
liquid chromatography–mass spectrometry or gas chroma-
tography–mass spectrometry with or without enzymatic hy-
drolysis before analysis, giving a total of six methods.
Polyphenol metabolites are often analyzed after enzymatic
hydrolysis to group together glucuronide and sulphate
esters and simplify the chromatograms.
Table 1. Search strategy and terms
Search steps Search terms Number of
publications
1 urin* or plasma* or metabol* >100 000
2 Dietary intake or intake* or exposure* or consum* or supplementation* or dietary supplements or
supplement* or intervention study or experiment* or exp clinical trial or interven* or feasibility
study or pilot study
>100 000
3 Human* or volunteer* or participant* or subject* or rat* or mouse* or mice* or rabbit* or pig* or
sheep* or ewe* or dog*
>100 000
4 Polyphenol* or flavan* or flavon*or anthocyan* or isoflav* or phytoestrogen* or phyto-estrogen*
or lignin* or stilbene* or chalcon* or phenolic acid* or ellagic* or coumarin* or hydroxycin-
namic* or quercetin* or kaempferol* or rutin* or apigenin* or luteolin* or catechin* or epica-
techin* or gallocatechin* or epigallocatechin* or procyanidin* or hesperetin* or naringenin* or
cyanidin* or malvidin* or petunid* or peonid*or daidz* or genist* or glycit* or equol* or gallic*
or vanillic* or chlorogenic* or tyrosol* or hydoxytyrosol* or resveratrol* or viniferin*
>100 000
5 Steps 1–4 combined 10780
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Food composition
If the polyphenol composition of the dose was specified in
the publication, it was entered in this table in the same way
as for the food composition data. Polyphenol compositions
of experimental foods and supplements were entered in
addition to those of normal foods. Compounds that were
not precisely chemically defined were omitted. Food com-
position data from metabolism studies were not aggre-
gated with existing data from the first release used to
produce mean polyphenol content values in foods but
were kept separate for display with individual intervention
studies.
Interventions
Studies carried out in each publication were split into sep-
arate interventions, each being a combination of a dose
type or source, dose quantity administered and organism.
All aspects of the intervention study design as described in
the publication were recorded, such as information on
number of subjects/animals, doses (multiple or single) and
duration of intervention.
Biofluid composition
This table is analogous to the Food composition table,
and each record corresponds to one metabolite de-
tected or quantified in the intervention study. Each
record contains information on the metabolite as
described, a numeric identifier based on the polyphenol
class and subclass, the analytical method used, details of
sample preparation and any enzymatic hydrolysis, a
plasma or urinary time course with up to six time points
(baseline and five subsequent time points of any duration),
Cmax, Tmax, T1/2, AUC and urinary recovery. Biofluid compos-
ition data were extracted from the text, tables and figures
of each publication.
The MS Access database was finally exported to a
MySQL database, which is able to feed the web
interface. The Phenol-Explorer site is built in the Ruby on
Rails (RoR) framework (http://www.rubyonrails.org). RoR
employs the Model-View-Controller design pattern and
allows the construction of a reliable and responsive web
application. The publicly accessible Phenol-Explorer 2.0
web server runs from an Apache 2 web server on a
Debian Linux system.
Figure 1. Scheme showing process of literature review and data inclusion.
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Querying and output
Metabolism information is retrieved in the same way as
food composition information, although searches have
been enhanced and refined. The ‘simple search’ has been
retained from the first release and allows the entry of terms
into a search box in the top-right hand corner of any page
on the site. When a search term, i.e. a name of a food,
polyphenol or polyphenol metabolite, is entered, a list of
matching items is displayed in the form of boxes, which
contain links to data. For example, if ‘wine’ is typed, eight
matching foods and four matching food groups are dis-
played. These boxes are visually oriented and contain
photographs of foods or chemical structures for phenolic
compounds, and more detailed data are accessed by hyper-
links. In the first release, food boxes contained the links
‘show polyphenol content’ and ‘show polyphenol distribu-
tion’. For the second release, these are now supplemented
with ‘show metabolites’, where available. Similarly, poly-
phenol boxes contain the additional link ‘show pharmaco-
kinetics’ in addition to ‘show content in foods’. There is also
a new box type for matches corresponding to polyphenol
metabolites. In the same way as for polyphenols, a chemical
structure is shown, accompanied by the single link ‘show
food sources and pharmacokinetics’. If a compound is both
a food component and metabolite, it appears separately as
both a ‘polyphenol’ and a ‘polyphenol metabolite’, distin-
guishing the routes taken to arrive at food composition or
metabolism data. Therefore, after the retrieval of a food or
compound or interest using the simple search, the user
chooses whether to then pursue food composition or
in vivo metabolism data.
Alternatively, data may be retrieved using links in
the main toolbar, which appears at the top of every
page. This toolbar allows the complete list of foods, food
polyphenols or polyphenol metabolites to be browsed. The
‘Metabolism’ tab is new for Phenol-Explorer 2.0, and the
user is able to browse the whole list of metabolites
(Figure 3). This list may be filtered by polyphenol class
and subclass using a scrolling box at the top of the
screen. For each metabolite, the molecular weight, species
in which identified, biofluid and the number of references
in which detected are shown. New text boxes at the top of
each column allow the further filtering of data according to
Publications
-#ID
-Authors
Interventions
-#ID
-Polyphenol source ID
-Publication date
-Title
-Journal
-Source as described
-Dose unit
-Dose quantity
-Single/multiple dose
-Organism
Foods (PP sources)
-#ID
-Class
-Plant variety
Scientific name
-Total subjects
-Intervention duration
-Washout duration
Biofluid Composition
-#ID
-Compound ID
-Compound name
-  
-Botanical family
-Food group code
Compounds
-#ID
-Name
-Synonyms
Class
 
-Quantified Y/N
-Method
-Biofluid
-Subjects used
Hydrolysis
Food Composition
-#ID
-Food
C d
-
-Subclass
-Family
-Formula
-Molecular weight
-
-Method of extraction
-Biofluid
-Unit
-Timepoint 1
- ompoun
-Publication
-Method
-Original food name
-Original content value
Methods
-Aglycone name
-Aglcyone mol wt
-Timepoint 2 etc
-Conc or amount at T0
-Conc or amount at T1
-Conc or amount at T2 etc
-Cmax
-Calculated content value
-Number of samples
-Quantified as
-Expressed as
-Brand
-#ID
-Name
-Journal
-Author
-Tmax
-AUC
-Half life
-Urinary recovery
-Extraction procedure
-Unit
-Quantity
-Pages
Figure 2. Entity-relationship diagram of the Phenol-Explorer 2.0 database showing new tables.
.............................................................................................................................................................................................................................................................................................
Page 5 of 8
Database, Vol. 2012, Article ID bas031, doi:10.1093/database/bas031 Database update
.............................................................................................................................................................................................................................................................................................
these criteria. A clickable button links to a list of all sources
(foods, food extracts or pure compounds) that have led to
the detection of a given metabolite in either urine or
plasma.
Upon retrieval of a food, a link leads directly to a list of
all metabolites identified after consumption of that food,
which is displayed in the form of a data table (Figure 4).
Metabolite identified in biofluids, composition of the
source, range of doses administered, number of recipients
of the dose, total number of subjects, urinary and plasma
pharmacokinetic data and reference information are dis-
played. Urinary pharmacokinetic data consist of two col-
umns, one for mean urinary excretion and another for a
graph icon, if a time course of excretion is available.
Plasma pharmacokinetic data are further divided into five
columns, one for each of Tmax, Cmax, T1/2, AUC and another
for a graph icon, if a plasma concentration time course is
available. Metabolites are grouped according to whether
they were detected before or after enzymatic deconjuga-
tion and by human or animal studies.
Phenol-Explorer 2.0 is, to the best of our knowledge, the
first searchable database to contain urinary excretion and
plasma concentration time courses for any metabolites
formed in humans or experimental animals. These graphs
are displayed by clicking on the graph icon corresponding
to a particular polyphenol source or metabolite (Figure 4).
References are displayed at the top of the page followed by
the graph(s) and corresponding data in tabular format. If
more than one quantity of the same dose was adminis-
tered, the corresponding curves are overlaid. In addition,
there is a tick box (‘show related metabolites from the same
publication’) allowing the user to overlay comparable data
from the same study, such as different metabolites after
administration of the same polyphenol source or the
same metabolite after administration of experimental and
control foods.
Discussion
Metabolism studies were variable in their design, and cer-
tain rules for handling different doses and time scales, ana-
lytical methods and units had to be fixed for data entry. In
many studies, a single dose was given, and biofluids were
taken for analysis at one or more time points after this
dose. In others, the same dose was repeated continuously
over a certain time or incorporated as part of a standar-
dized diet (in the case of animal studies). Output data re-
sulting from repeated doses are clearly marked as such. The
dose unit is then usually expressed in weight unit per day
and the time period over which the dose was repeated
clearly stated.
A limited number of conjugated polyphenol metabolites
(53 glucuronides and 23 sulfate esters) have been fully iden-
tified in the literature, mainly due to the limited availability
of commercial standards. Polyphenol metabolites have
more often been identified as aglycones after hydrolysis
by b-glucuronidase and sulfatase enzymes. Therefore, ana-
lytical data obtained with and without enzymatic deconju-
gation are reported separately.
Plasma and urinary pharmacokinetic data were ex-
pressed in publications in a wide range of units. The treat-
ment of plasma data was more straightforward than that
of urinary data, because the former are almost always point
concentrations expressed in moles or weights per volume.
Plasma concentrations expressed as weights per volume
were converted to molar concentrations for easier compari-
son. Urinary data may also be point concentrations.
Excretion values are sometimes normalized by creatinine
Simple search
Main 
toolbar
Filters
Figure 3. Phenol-Explorer 2.0 page layout and search methods.
.............................................................................................................................................................................................................................................................................................
Page 6 of 8
Database update Database, Vol. 2012, Article ID bas031, doi:10.1093/database/bas031
.............................................................................................................................................................................................................................................................................................
excretion but are more commonly expressed as an amount
excreted, in moles or grams, during a particular time
period. They may also be expressed as a percentage of
the polyphenol dose in intervention studies with pure poly-
phenols or when the nature of the ingested polyphenol can
be identified without any ambiguity. Urinary data could
not be standardized to a common unit, as creatinine con-
centration and urine volume are most often missing from
the publication. The original unit was therefore retained.
To graphically represent amounts of metabolite excreted
over given time periods (such as 0–2 h and 2–5h), amounts
of metabolite excreted were summed to produce cumula-
tive urinary excretion curves.
The database allows various fundamental questions on
food polyphenol metabolites to be answered. The main aim
of Phenol-Explorer 1.0 was to easily retrieve the polyphenol
content of a food of interest. Phenol-Explorer 2.0 now
allows to retrieve all reliably identified plasma and urinary
metabolites formed from a given food, food extract or pure
polyphenol. Therefore, while the user could previously
obtain an instant estimate of the polyphenol intake from
an intervention study dose, Phenol-Explorer 2.0 enables the
display of all metabolites identified in plasma and urine,
along with plasma concentrations, pharmacokinetics and
a minimum extent of absorption as estimated by urinary
recovery. Similarly, if the researcher was interested in a par-
ticular polyphenol, they could instantly find out from
Phenol-Explorer 1.0 which foods provide that polyphenol.
With the second release, researchers interested in a particu-
lar polyphenol metabolite (whose bioactivity may have
been postulated from in vitro studies) may instantly recall
a list of foods known to give rise to that metabolite. This
information is key in the identification of putative bio-
markers of exposure specific to different dietary polyphe-
nols and can be used to better characterize exposure in
population studies (16).
In addition, every effort has been made to retain com-
parisons between polyphenols and sources made in a given
intervention study; if the plasma time course of a metabol-
ite of interest is recalled, a link then allows the graphical
Figure 4. Tabular and graphical data output from Phenol-Explorer 2.0.
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comparison of different metabolites examined in the same
study. Phenol-Explorer 2.0, as well as providing answers to
general questions on polyphenol metabolism, incorporates
the comparisons made within individual metabolism
studies.
Phytochemical databases were recently reviewed (17),
and Phenol-Explorer 2.0 is the first to include chemical in-
formation on this important class of phytochemicals as well
as comprehensive information on food composition, metab-
olism and pharmacokinetics. Databases containing metab-
olism and pharmacokinetics data for certain drugs are
already available (18, 19), although Phenol-Explorer is the
first to contain similar data for natural or dietary com-
pounds and to allow all retrieved information to be traced
back to the original publications. It is also unique in that all
intervention studies have been systematically analyzed and
relevant data comprehensively curated. The database will
be periodically updated to ensure that the current state of
polyphenol metabolism research is adequately represented.
Conclusions
Phenol-Explorer was initially conceived to allow the re-
trieval of screened and aggregated compositions of poly-
phenols in foods, enabling definitive data to be obtained in
a matter of seconds and saving the user the time and effort
of manual literature searches. Similar objectives were in-
tended for Phenol-Explorer 2.0 and its metabolism data.
We believe that this update has transformed Phenol-
Explorer to a more comprehensive polyphenol knowledge
base, especially when food composition data are used in
tandem with metabolism data. Phenol-Explorer 2.0 should
greatly aid the advance of the understanding of the rela-
tions between polyphenol consumption and health by
helping researchers design and interpret studies on these
important dietary components.
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